Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 6/2010

01.12.2010 | Gynecologic Oncology

Clinicopathological and immunohistochemical analysis of sclerosing stromal tumours of the ovary

verfasst von: Osman Zekioglu, N. Ozdemir, C. Terek, A. Ozsaran, Y. Dikmen

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Sclerosing stromal tumours (SST) of the ovary are rare, benign tumours. SSTs are usually hormone inactive and tend to occur in the second and third decades of life. The most common clinical symptom is menstrual irregularity.

Materials and methods

Fourteen women diagnosed with SST of the ovary were included in this study. Tumour samples were collected, embedded in paraffin and stained with haematoxylin and eosin, periodic acid-Schiff (PAS), and PAS with digestion, as well as immunohistochemically for vimentin, smooth muscle actin, desmin, CD 99, inhibin-α and the oestrogen and progesterone receptor.

Results

The age of the patients ranged from 16 to 54 years (mean age 25.2 years). The tumours ranged in size from 6 to 21 cm (mean 10.5 cm). Macroscopically, eight tumours were solid and six were solid and cystic. All SSTs were well circumscribed with pseudolobule formation. Spindle-shaped fibroblast-like cells and vacuolated theca-like cells were prominent. Blood vessels exhibited a hemangiopericytomatous pattern and boomerang-like features. Immunohistochemical results were as follows: vimentin, 14/14 cases positive; smooth muscle actin, 14/14 cases positive; desmin, 14/14 cases positive; CD 99, 4/14 cases positive; inhibin-α, 14/14 cases positive; oestrogen receptor, 0/14 cases positive; progesterone receptor, 2/14 cases positive.

Conclusions

The characteristic histopathological features we observed in our study are usually adequate for the diagnosis of SSTs. Although inhibin-α, CD 99 and desmin staining may be a useful and reliable tool for SST diagnosis in problematic cases, an immunohistochemical panel will not discriminate from other tumours in the sex cord-stromal group.
Literatur
1.
2.
Zurück zum Zitat Kawauchi S, Tsuji T, Kaku T et al (1998) Sclerosing stromal tumor of the ovary: a clinicopathologic, immunohistochemical, ultrastructural and cytogenetic analysis with special reference to its vasculature. Am J Surg Pathol 22:83–92CrossRefPubMed Kawauchi S, Tsuji T, Kaku T et al (1998) Sclerosing stromal tumor of the ovary: a clinicopathologic, immunohistochemical, ultrastructural and cytogenetic analysis with special reference to its vasculature. Am J Surg Pathol 22:83–92CrossRefPubMed
3.
Zurück zum Zitat Hsu C, Ma L, Mak L (1983) Sclerosing stromal tumor of the ovary: case report and review of the literature. Int J Gynecol Pathol 2:192–200CrossRefPubMed Hsu C, Ma L, Mak L (1983) Sclerosing stromal tumor of the ovary: case report and review of the literature. Int J Gynecol Pathol 2:192–200CrossRefPubMed
4.
Zurück zum Zitat Quinn MA, Oster AO, Fortune D, Hudson B (1981) Sclerosing stromal tumor of the ovary: case report with endocrine studies. Br J Obstet Gynecol 88:555–558 Quinn MA, Oster AO, Fortune D, Hudson B (1981) Sclerosing stromal tumor of the ovary: case report with endocrine studies. Br J Obstet Gynecol 88:555–558
5.
Zurück zum Zitat Tsukamoto N, Nakamura M, Ishikawa H (1976) Sclerosing stromal tumor of the ovary. Gynecol Oncol 4:335–339CrossRefPubMed Tsukamoto N, Nakamura M, Ishikawa H (1976) Sclerosing stromal tumor of the ovary. Gynecol Oncol 4:335–339CrossRefPubMed
6.
7.
Zurück zum Zitat Ismail SM, Walker SM (1990) Bilateral virilizing sclerosing stromal tumors of the ovary in a pregnant woman with Gorlin’s syndrome: implications for pathogenesis of ovarian stromal neoplasms. Histopathology 17:159–163CrossRefPubMed Ismail SM, Walker SM (1990) Bilateral virilizing sclerosing stromal tumors of the ovary in a pregnant woman with Gorlin’s syndrome: implications for pathogenesis of ovarian stromal neoplasms. Histopathology 17:159–163CrossRefPubMed
8.
Zurück zum Zitat Marelli G, Carinelli S, Mariani A, Frigerio L, Ferrari A (1998) Sclerosing stromal tumor of the ovary: report of eight cases and review of the literature. Eur J Obstet Gynecol 76:85–89CrossRef Marelli G, Carinelli S, Mariani A, Frigerio L, Ferrari A (1998) Sclerosing stromal tumor of the ovary: report of eight cases and review of the literature. Eur J Obstet Gynecol 76:85–89CrossRef
9.
Zurück zum Zitat Damjanov I, Drobnjak P, Grizelj V, Longhino N (1975) Sclerosing stromal tumor of the ovary: a hormonal and ultrastructural analysis. Obstet Gynecol 45:675–679CrossRef Damjanov I, Drobnjak P, Grizelj V, Longhino N (1975) Sclerosing stromal tumor of the ovary: a hormonal and ultrastructural analysis. Obstet Gynecol 45:675–679CrossRef
10.
Zurück zum Zitat Shaw JA, Dabbs DJ, Geisinger KR (1992) Sclerosing stromal tumor of the ovary: an ultrastructural and immunohistochemical analysis with histogenetic considerations. Ultrastruc Pathol 16:363–377CrossRef Shaw JA, Dabbs DJ, Geisinger KR (1992) Sclerosing stromal tumor of the ovary: an ultrastructural and immunohistochemical analysis with histogenetic considerations. Ultrastruc Pathol 16:363–377CrossRef
11.
Zurück zum Zitat Lam RMY, Geittmann P (1988) Sclerosing stromal tumor of the ovary: a light, electron microscopic and enzyme histochemical study. Int J Gynecol Pathol 7:280–290CrossRefPubMed Lam RMY, Geittmann P (1988) Sclerosing stromal tumor of the ovary: a light, electron microscopic and enzyme histochemical study. Int J Gynecol Pathol 7:280–290CrossRefPubMed
12.
Zurück zum Zitat Sasano H, Mori T, Sasano N, Nagura H, Mason JL (1990) Immunolocalization of 3-a-hydroxysteroid dehydrogenase in human ovary. J Reprod Fertil 89:743–751CrossRefPubMed Sasano H, Mori T, Sasano N, Nagura H, Mason JL (1990) Immunolocalization of 3-a-hydroxysteroid dehydrogenase in human ovary. J Reprod Fertil 89:743–751CrossRefPubMed
13.
Zurück zum Zitat Lifschitz-Mercer B, Open M, Kushnir I, Jacob N, Czernobilsky B (1995) Hyaline globules and progesterone receptors in an ovarian sclerosing stromal tumor. Histopathology 27:195–197CrossRefPubMed Lifschitz-Mercer B, Open M, Kushnir I, Jacob N, Czernobilsky B (1995) Hyaline globules and progesterone receptors in an ovarian sclerosing stromal tumor. Histopathology 27:195–197CrossRefPubMed
14.
Zurück zum Zitat Saitoh A, Tsutsumi Y, Osamura Y, Watanabe K (1989) Sclerosing stromal tumor of the ovary: immunohistochemical and electron microscopic demonstration of smooth muscle differentiation. Arch Pathol Lab Med 113:372–376PubMed Saitoh A, Tsutsumi Y, Osamura Y, Watanabe K (1989) Sclerosing stromal tumor of the ovary: immunohistochemical and electron microscopic demonstration of smooth muscle differentiation. Arch Pathol Lab Med 113:372–376PubMed
15.
Zurück zum Zitat Santini D, Ceccarelli C, Leone D et al (1995) Smooth muscle differentiation in normal human ovaries, ovarian stromal hyperplasia, and ovarian granulosa-stroma cell tumours. Mod Pathol 8:25–30PubMed Santini D, Ceccarelli C, Leone D et al (1995) Smooth muscle differentiation in normal human ovaries, ovarian stromal hyperplasia, and ovarian granulosa-stroma cell tumours. Mod Pathol 8:25–30PubMed
16.
Zurück zum Zitat Baker PM, Oliva E (2004) Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update. Int J Gynecol Pathol 24:39–55 Baker PM, Oliva E (2004) Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update. Int J Gynecol Pathol 24:39–55
17.
Zurück zum Zitat Kommoss F, Oliva E, Bhan K, Young RH, Scully RE (1998) Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Mod Pathol 11:656–664PubMed Kommoss F, Oliva E, Bhan K, Young RH, Scully RE (1998) Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Mod Pathol 11:656–664PubMed
18.
Zurück zum Zitat Stewart CS, Nandini CL, Richmond JA (2000) Value of A103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord-stromal tumors. J Clin Pathol 53:206–211CrossRefPubMed Stewart CS, Nandini CL, Richmond JA (2000) Value of A103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord-stromal tumors. J Clin Pathol 53:206–211CrossRefPubMed
19.
Zurück zum Zitat McCluggage WG, Maxwell P (2001) Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord-stromal tumours. Histopathology 38:403–408CrossRefPubMed McCluggage WG, Maxwell P (2001) Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord-stromal tumours. Histopathology 38:403–408CrossRefPubMed
20.
Zurück zum Zitat Zhao C, Vinh NT, McManus K, Dabbs D, Barner R, Vang R (2009) Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. Am J Surg Pathol 33:354–366CrossRefPubMed Zhao C, Vinh NT, McManus K, Dabbs D, Barner R, Vang R (2009) Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. Am J Surg Pathol 33:354–366CrossRefPubMed
21.
Zurück zum Zitat Cathro HP, Stoler MH (2005) The utility of calretinin, inhibin, and WT-1 immunohistochemical staining in the differential diagnosis of ovarian tumors. Hum Pathol 36:195–201CrossRefPubMed Cathro HP, Stoler MH (2005) The utility of calretinin, inhibin, and WT-1 immunohistochemical staining in the differential diagnosis of ovarian tumors. Hum Pathol 36:195–201CrossRefPubMed
22.
Zurück zum Zitat Deavers MT, Malpica A, Liu J, Broaddus R, Silva E (2003) Ovarian sex cord-tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol 16:584–590CrossRefPubMed Deavers MT, Malpica A, Liu J, Broaddus R, Silva E (2003) Ovarian sex cord-tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol 16:584–590CrossRefPubMed
23.
Zurück zum Zitat Movahedi-Lankarani S, Kurman RJ (2002) Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases. Am J Surg Pathol 26:1477–148 Movahedi-Lankarani S, Kurman RJ (2002) Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases. Am J Surg Pathol 26:1477–148
24.
Zurück zum Zitat Shah VI, Freites ON, Maxwell P, McCluggage WG (2003) Inhibin is more specific than calretinin as an immunohistochemical marker for differentiating sarcomatoid granulosa cell tumour of the ovary from other spindle cell neoplasms. J Clin Pathol 56:221–224CrossRefPubMed Shah VI, Freites ON, Maxwell P, McCluggage WG (2003) Inhibin is more specific than calretinin as an immunohistochemical marker for differentiating sarcomatoid granulosa cell tumour of the ovary from other spindle cell neoplasms. J Clin Pathol 56:221–224CrossRefPubMed
25.
Zurück zum Zitat Oliva E, Garcia-Miralles N, Vu Q, Young RH (2007) CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases. Int J Gynecol Pathol 26:359–367CrossRefPubMed Oliva E, Garcia-Miralles N, Vu Q, Young RH (2007) CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases. Int J Gynecol Pathol 26:359–367CrossRefPubMed
26.
Zurück zum Zitat McCluggage WG, McKenna M, McBride HA (2007) CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors. Int J Gynecol Pathol 26:322–327CrossRefPubMed McCluggage WG, McKenna M, McBride HA (2007) CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors. Int J Gynecol Pathol 26:322–327CrossRefPubMed
27.
Zurück zum Zitat Tiltman AJ, Haffajee Z (1999) Sclerosing stromal tumors, thecomas, and fibromas of the ovary: an immunohistochemical profile. Int J Gynecol Pathol 18:254–258CrossRefPubMed Tiltman AJ, Haffajee Z (1999) Sclerosing stromal tumors, thecomas, and fibromas of the ovary: an immunohistochemical profile. Int J Gynecol Pathol 18:254–258CrossRefPubMed
28.
Zurück zum Zitat Suarez A, Palacios J, Burgos E, Gamallo C (1993) Signet ring stromal tumor of the ovary: a histochemical, immunohistochemical and ultrastructural study. Virchow Archiv 422:333–336CrossRef Suarez A, Palacios J, Burgos E, Gamallo C (1993) Signet ring stromal tumor of the ovary: a histochemical, immunohistochemical and ultrastructural study. Virchow Archiv 422:333–336CrossRef
29.
Zurück zum Zitat Nucci MR, Oliva E (2009) Gynecologic Pathology. In: Deaver MT, Oliva E, Nucci MR (eds). Sex cord-stromal tumors of the ovary. Elsevier Churcill Livingstone, 457–460 Nucci MR, Oliva E (2009) Gynecologic Pathology. In: Deaver MT, Oliva E, Nucci MR (eds). Sex cord-stromal tumors of the ovary. Elsevier Churcill Livingstone, 457–460
30.
Zurück zum Zitat Irving AJ, Young RH (2009) Microcystic stromal tumor of the ovary: report of 16 cases of a hitherto uncharacterized distinctive ovarian neoplasm. Am J Surg Pathol 33:367–375CrossRefPubMed Irving AJ, Young RH (2009) Microcystic stromal tumor of the ovary: report of 16 cases of a hitherto uncharacterized distinctive ovarian neoplasm. Am J Surg Pathol 33:367–375CrossRefPubMed
Metadaten
Titel
Clinicopathological and immunohistochemical analysis of sclerosing stromal tumours of the ovary
verfasst von
Osman Zekioglu
N. Ozdemir
C. Terek
A. Ozsaran
Y. Dikmen
Publikationsdatum
01.12.2010
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 6/2010
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1373-9

Weitere Artikel der Ausgabe 6/2010

Archives of Gynecology and Obstetrics 6/2010 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.